West Pharmaceutical Services Inc.
The stock is very clear, forming a downward trend that has been tested multiple times. As you can see, the strength of the recent decline is evident. The current price of the stock is $314.5. The sell entry point is at this level. Our first target is a new low below $265, and our second target is a low below $205.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.